Coronavirus and the crisis of medicine
Abstract
The Covid 19 epidemic has an unprecedented media component in the history of medicine, this added to the lack of leadership of governments and specialized institutions, has generated thousands of voices with equivocal messages, generated from personal experiences and not from a scientific method. This editorial is a wake-up call to the ineffectiveness shown in decision-making and implementation of health policies, which have been taken in the heat of the moment
Downloads
References
2. Nussbaumer-Streit B, Mayr V, Dobrescu AIulia, Chapman A, Persad E, Klerings I, Wagner G, Siebert U, Christof C, Zachariah C,Gartlehner G. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review. Cochrane Database of Systematic Reviews 2020, Issue 4. Art. No.: CD013574. DOI: 10.1002/14651858.CD013574
3. Mia, A., Griffiths, M. Letter to the Editor: The economic and mental health costs of COVID-19 to immigrants, Journal of Psychiatric Research 128 (2020) https://doi.org/10.1016/j.jpsychires.2020.06.003
4. British Lung Foundation. Coronavirus and COVID-19: What is social shielding and who needs to do this? 2020. Disponible en: https://www.blf.org.uk/support-for-you/coronavirus/what-is-social-shielding
5. Organización Mundial de la Salud. Recomendaciones sobre el uso de mascarillas en el contexto de la COVID-19: orientaciones provisionales, 6 de abril de 2020. Organización Mundial de la Salud. https://apps.who.int/iris/handle/10665/331789. License: CC BY-NC-SA 3.0 IGO)
6. Mingming Lianga,Liang Gaoc,Ce Cheng, Qin Zhoue,and others,Efficacy of face mask in preventing respiratory virus transmission: A systematic review and meta-analysis, Travel Medicine and Infectious Disease, May, 2020
7. (Cowling BJ, Fung RO, Cheng CK, Fang VJ, Chan KH, Seto WH, et al. Preliminary findings of a randomized trial of non-pharmaceutical interventions to prevent influenza transmission in households. PloS One 2008;3:e2101https://doi.org/10. 1371/journal.pone.0002101.)
8. Cowling BJ, Chan K, Fang VJ, Cheng CK, Fung RO, Wai W, et al. Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. Ann Intern Med 2009;151:437–46)
9. Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020;178:104787. doi:10.1016/j.antiviral.2020.104787
10. Chaccour C, Hammann F, Ramón-García S, Rabinovich NR. Ivermectin and COVID-19: Keeping Rigor in Times of Urgency. Am J Trop Med Hyg. 2020;102(6):1156-1157. doi:10.4269/ajtmh.20-0271
11. Gautret, P., Lagier, J.C., Parola, P., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V.E., Dupont, H.T. and Honoré, S., 2020. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents, p.105
12. Rosenberg ES, Dufort EM, Udo T, et al. Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State [published online ahead of print, 2020 May 11]. JAMA. 2020;323(24):2493-2502. doi:10.1001/jama.2020.8630
Copyright (c) 2020 Rural Family Practice

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.